Evidence map›Paper›PMID 32377523›Full record

Trial reportJournal of diabetes research2020

Carrageenan-Free Diet Shows Improved Glucose Tolerance and Insulin Signaling in Prediabetes: A Randomized, Pilot Clinical Trial.

Leo Feferman, Sumit Bhattacharyya, Erin Oates, Nicole Haggerty, Tianxiu Wang, Krista Varady, Joanne K Tobacman

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of diabetes research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Encapsulation ofNanomaterials (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Processed Foods - Getting Back to The Basics.Current gastroenterology reports · 2021
    Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Leo FefermanDepartment of Medicine, College of Medicine, University of Illinois at Chicago and Jesse Brown VA Medical Center, Chicago, IL, USA.
Sumit BhattacharyyaDepartment of Medicine, College of Medicine, University of Illinois at Chicago and Jesse Brown VA Medical Center, Chicago, IL, USA.
Erin OatesDepartment of Nutrition, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL, USA.
Nicole HaggertyDepartment of Nutrition, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL, USA.
Tianxiu WangDepartment of Epidemiology and Biostatistics, College of Public Health, University of Illinois at Chicago, Chicago, IL, USA.
Krista VaradyDepartment of Nutrition, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL, USA.ORCID https://orcid.org/0000-0002-9279-9934
Joanne K TobacmanDepartment of Medicine, College of Medicine, University of Illinois at Chicago and Jesse Brown VA Medical Center, Chicago, IL, USA.ORCID https://orcid.org/0000-0002-7220-3419
University of Illinois Chicago · US

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
NCATS NIH HHS UL1 TR002003
6 · The paper itself

Abstract

objectivesCarrageenan is well known to cause inflammation and is used in laboratory experiments to study mediators and treatments of inflammation. However, carrageenan is added to hundreds of processed foods to improve texture. Previous work indicated that low concentrations of carrageenan in drinking water caused marked glucose intolerance and insulin resistance in a mouse model. This exploratory, clinical study tested the impact of the no-carrageenan diet in prediabetes.

resultsSubjects on no carrageenan had declines in HbA1c and HOMA-IR (

conclusionsFindings indicate improvement in HbA1c and HOMA-IR in participants on no-carrageenan diets, but not in participants on carrageenan-containing diets. Significant differences between groups suggest that removing carrageenan may improve insulin signaling and glucose tolerance. Larger studies are needed to further consider the impact of carrageenan on development of diabetes.

Indexed as

CarrageenanDietAdultBlood GlucoseFemaleGlucose IntoleranceHumansInsulinInsulin ResistanceMaleMiddle AgedPilot ProjectsPrediabetic StateYoung AdultBlood GlucoseCarrageenanInsulin

Identifiers

PMID32377523
PMCPMC7191375
OpenAlexW3019518498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.